Drugs / THV01-2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02054286 | Dec 2012 → Aug 2014 | HIV infectious disease | Theravectys S.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | THV01-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02054286 ↗ |
| Route | Intramuscular | “Intramuscular injection of THV01-2 (week 8)” NCT02054286 ↗ |